HIMS Stock Risk & Deep Value Analysis
Hims & Hers Health Inc
Healthcare • Drug Manufacturers - Specialty & Generic
DVR Score
out of 10
What You Need to Know About HIMS Stock
We analyzed Hims & Hers Health Inc using our deep value framework. Sign in to see our full verdict and DVR Score.
We ran HIMS through our deep value framework — analyzing financial health, distress signals, competitive moat, and risk factors. Our risk assessment: Moderate. Here's what we found.
How Risky Is HIMS Stock?
Overall Risk
Moderate
Financial Risk
Low
Market Risk
Medium
Competitive Risk
High
Execution Risk
Medium
Regulatory Risk
High
What Are the Red Flags for HIMS?
- ⚠
Increased regulatory scrutiny on telehealth prescriptions or GLP-1 marketing
- ⚠
Stronger-than-expected competitive entry or execution by rivals
- ⚠
Disappointing Q1 2026 earnings or guidance miss, especially on subscriber growth
- ⚠
Supply chain disruptions affecting GLP-1 or other key medication availability
Unlock HIMS Red Flags & Risk Warnings
Create a free account to see the full analysis
What Does Hims & Hers Health Inc (HIMS) Do?
Market Cap
$7.44B
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
1,637
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. The company also provides Labs which measures key markers over time and provides doctor-developed action plans. Hims & Hers Health, Inc. is based in San Francisco, California.
Visit Hims & Hers Health Inc WebsiteIs HIMS Stock Undervalued?
Unlock the full AI analysis for HIMS
Get the complete DVR score, risk analysis, and more
Is HIMS Financially Healthy?
P/E Ratio
61.68
Does HIMS Have a Competitive Moat?
Sign in to unlockMoat Rating
🛡️ Narrow
Moat Trend
Expanding
Moat Sources
3 Identified
HIMS's moat is driven by its strong brand affinity in a personalized health context, creating customer loyalty. The integrated platform (telehealth, pharmacy, fulfillment) raises switching costs. Continued investment in proprietary technology and data analytics further strengthens its competitive position, making it harder for new entrants to replicate the full-stack experience.
Moat Erosion Risks
- •Aggressive pricing strategies and similar offerings from well-funded competitors (e.g., Amazon, CVS Health)
- •Adverse regulatory changes that could impact its direct-to-consumer model or specific drug categories
- •Loss of brand trust due to negative publicity or service quality issues
HIMS Competitive Moat Analysis
Sign up to see competitive advantages
What Could Drive HIMS Stock Higher?
Near-Term (0-6 months)
- •Q1 2026 Earnings Report (Estimated early-May 2026)
- •Expansion of GLP-1 weight management program (e.g., new formulations, increased access)
- •Launch of new mental health or chronic care services/features
Medium-Term (6-18 months)
- •Further penetration into new states or potential international markets
- •Strategic partnerships with healthcare providers or major employers
- •Continued growth in subscriber base and average revenue per user (ARPU)
Long-Term (18+ months)
- •Establishment as a leading, vertically integrated digital health platform
- •Significant disruption of traditional primary care for chronic conditions
- •Leveraging AI/ML for hyper-personalized treatment plans and improved patient outcomes
Catalysts & Growth Drivers
Upgrade to Premium to see catalysts
What's the Bull Case for HIMS?
- ✓
Acceleration in subscriber growth and ARPU, particularly within chronic care segments
- ✓
Sustained gross margin expansion and continued positive free cash flow generation
- ✓
Successful expansion into new therapeutic areas or geographies
- ✓
Any significant shifts in telehealth or prescription drug regulatory environment
Bull Case Analysis
See what could go right with Premium
Compare HIMS to Similar Stocks
See how Hims & Hers Health Inc stacks up against related companies in our head-to-head analysis.
📊 Explore More Stock Analysis
Get comprehensive Deep Value Reports for thousands of stocks. Research risk, financial health, and investment potential with our AI-powered analysis.
Important Disclaimer – Not Financial Advice
Deep Value Reports is an independent research platform for educational and informational purposes only. We are not financial advisors, investment advisors, or licensed professionals. The analysis, scores, and information provided on this page for HIMS (Hims & Hers Health Inc) should not be construed as personalized investment advice, a recommendation to buy or sell any security, or an offer to provide investment advisory services.
All investments involve risk, including the potential loss of principal. Past performance does not guarantee future results. Always conduct your own research, consider your financial situation, and consult with a qualified financial advisor before making any investment decisions.
